Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study

被引:9
|
作者
Qian, Subo [1 ]
Zhang, Shun [1 ]
Xia, Weimin [1 ]
Xu, Ding [1 ]
Qi, Jun [1 ]
Shen, Haibo [1 ]
Wu, Yu [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Urol, Xinhua Hosp, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
来源
PROSTATE | 2021年 / 81卷 / 08期
关键词
benign prostatic hyperplasia; cross‐ sectional study; disease progression; logistic regression analysis; prostatic morphological parameters;
D O I
10.1002/pros.24128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Our study aimed to investigate the correlation of prostatic morphological parameters and benign prostatic hyperplasia (BPH) clinical progression in aging Chinese men. Methods In this retrospective study, a total of 1038 patients were reviewed. Prostatic morphology was measured by transrectal ultrasound (TRUS). Detailed medical history of all candidates was recorded and analyzed after being classified by specific prostatic measurements. Univariate and multivariate logistic regression analyses were used to estimate the correlation between variables. Results The cumulative incidence of BPH clinical progression was 63.68% (661/1038) in the study population. Prostate volume (PV), transitional zone volume (TZV), transitional zone index (TZI), and intravesical prostatic protrusion (IPP) were all positively associated with BPH progression (all p < .001). Patients with a PV > 60 ml, TZV > 15 ml, TZI > 0.5, or IPP > 5 mm had a significantly higher possibility of overall BPH clinical progression (adjusted odds ratio (OR): 2.485, 1.678, 1.886, and 1.924, respectively; 95% confidence interval (CI): 1.559-3.960, 1.131-2.489, 1.379-2.579, and 1.357-2.728, correspondingly). Conclusion Prostatic morphological parameters are significantly associated with BPH clinical progression. Patients with larger prostatic morphological parameters are more easily prone to clinical progress. As a result, reasonable managements should be timely considered for those patients before clinical progression occurs.
引用
收藏
页码:478 / 486
页数:9
相关论文
共 50 条
  • [21] Treatment satisfaction with low-dose tamsulosin for symptomatic benign prostatic hyperplasia: results from a multicentre cross-sectional survey
    Kim, J. H.
    Park, J. Y.
    Oh, M. M.
    Lee, J. G.
    Kwon, S. -S.
    Bae, J. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (12) : 1209 - 1215
  • [22] CORRELATION BETWEEN LIVER-CIRRHOSIS AND BENIGN PROSTATIC HYPERPLASIA - A MORPHOLOGICAL-STUDY
    FREA, B
    ANNOSCIA, S
    STANTA, G
    LOZZI, C
    CARMIGNANI, G
    UROLOGICAL RESEARCH, 1987, 15 (05): : 311 - 314
  • [23] Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo - Reply
    不详
    JOURNAL OF UROLOGY, 2006, 175 (04): : 1426 - 1427
  • [24] Relationship between serum indirect bilirubin and prostate volume in patients with benign prostatic hyperplasia: a cross-sectional study
    Ling, Cunbao
    Wu, Xingyu
    Huang, Wei
    Pang, Aibo
    Wu, Yangyang
    Wang, Xueyang
    Zhang, Chunyan
    Tian, Yaping
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (20)
  • [25] A Cross-Sectional Study for Association between Periodontitis and Benign Prostatic Hyperplasia Using the Korean Genome and Epidemiology Study Data
    Byun, Soo-Hwan
    Min, Chanyang
    Bang, Woojin
    Yang, Byoung-Eun
    Hong, Seok Jin
    Park, Sang Chul
    Choi, Hyo Geun
    COATINGS, 2022, 12 (02)
  • [26] Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey
    Huh, Jung-Sik
    Kim, Young-Joo
    Kim, Sung Dae
    WORLD JOURNAL OF MENS HEALTH, 2012, 30 (02): : 131 - 137
  • [27] Prostatic hyperplasia is highly associated with nocturia and excessive sleepiness: a cross-sectional study
    Chartier-Kastler, Emmanuel
    Leger, Damien
    Comet, Denis
    Haab, Francois
    Ohayon, Maurice M.
    BMJ OPEN, 2012, 2 (03):
  • [28] The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study
    Fu, Yongqiang
    Zhou, Zhe
    Yang, Bing
    Zhang, Kai
    He, Lijun
    Zhang, Xianghua
    UROLOGIA INTERNATIONALIS, 2016, 97 (03) : 330 - 335
  • [29] Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men
    Meigs, JB
    Mohr, B
    Barry, MJ
    Collins, MM
    McKinlay, JB
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (09) : 935 - 944
  • [30] Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
    Huri, Hasniza Zaman
    Xin, Chong Hui
    Sulaiman, Che Zuraini
    PLOS ONE, 2014, 9 (01):